Hepatitis B immunisation rates among infants in ethnic groups with high prevalences of hepatitis B surface antigen carriers.
To determine hepatitis B immunisation rates in infants from ethnic groups with hepatitis B surface antigen chronic carrier prevalence over 5 per cent, a questionnaire was sent to all Maternal and Child Health Centres in Victoria, requesting information on the hepatitis B and diphtheria-tetanus-pertussis (DTP) or combined diphtheria-tetanus (CDT) immunisation status for all infants born between 1 July 1992 and 30 June 1993 and at risk of hepatitis B infection because of maternal ethnicity. We received data on 3611 of 5744 infants (62.9 per cent) in targeted ethnic groups. Of these, 12.8 per cent had not received hepatitis B vaccine, and 81.6 per cent, 76.8 per cent and 64.0 per cent had received at least one, two and three doses respectively, while 84 per cent had received at least three doses of DTP vaccine and/or CDT vaccine. Coverage with DTP or CDT was higher than for hepatitis B vaccine (P < 0.001), and coverage was better in areas with a higher percentage of infants in high-prevalence ethnic groups (P < 0.001). Changes in the program in Victoria in terms of timing of the first dose of vaccine plus greater attention to follow-up may lead to improved hepatitis B immunisation rates among infants in targeted ethnic groups. Adoption of universal infant hepatitis B immunisation, by increasing familiarity with hepatitis B vaccine, is likely to be the best way to increase immunisation coverage for these infants.
Oman
K M
KM
Department of Human Services Victoria.
Carnie
J
J
Ruff
T A
TA
D002353:Carrier State / Q000097:blood / Q000208:ethnology*; D002908:Chronic Disease; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D006509:Hepatitis B / Q000097:blood / Q000208:ethnology*; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D017325:Hepatitis B Vaccines; D006801:Humans; D007223:Infant; D015995:Prevalence; D011795:Surveys and Questionnaires; D014611:Vaccination / Q000706:statistics & numerical data*; D014739:Victoria / Q000453:epidemiology
D015721:Diphtheria-Tetanus-Pertussis Vaccine; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines